Participating Faculty: Standards of Care Issues With Anticoagulation in Real-World Populations

Faculty

This supplement to The American Journal of Managed Care is the second in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE). The focus of this supplement is the issues and complexities surrounding the use of mainstay anticoagulation therapies in real-world populations. Discussions include the impact of comorbidities on international normalized ratio control and the potential impact that population health management and value-based care may have on improving outcomes in NVAF and VTE populations.

Jan Berger, MD, MJ—Moderator

President and CEO

Health Intelligence Partners

Chicago, Illinois

Donald C. Balfour III, MD, FACP

President and Medical Director

Sharp Rees-Stealy Medical Group

San Diego, California

Joseph E. Biskupiak, PhD, MBA

Research Professor

Department of Pharmacotherapy

College of Pharmacy, University of Utah

Salt Lake City, Utah

Jeffrey D. Dunn, PharmD, MBA

Senior Vice President

VRx Pharmacy Services, LLC

Salt Lake City, Utah

Dennis B. Liotta, MD, MBA

Former Chief of Pharmacy

EmblemHealth

New York, New York

Adjunct Professor

New York University

Stern School of Business

New York, New York

Geno J. Merli, MD, FACP, FHM, FSVM

Co-Director

Jefferson Vascular Center

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania

Professor of Medicine and Surgery

Sidney Kimmel Medical College

Thomas Jefferson University

Philadelphia, Pennsylvania

Edmund J. Pezalla, MD, MPH

Vice President

National Medical Director

Pharmaceutical Policy and Strategy

Aetna

Hartford, Connecticut

Fadia T. Shaya, PhD, MPH

Professor and Vice-Chair

Director of Research

Center for Innovative Pharmacy Solutions

University of Maryland, School of Pharmacy

Baltimore, Maryland

Tomás Villanueva, DO, MBA, FACPE, SFHM

Assistant Vice President and Medical Director

Baptist Health Medical Group

Miami, Florida

Faculty Disclosures

These faculty report relationships with the following organizations:

Jeffrey D. Dunn, PharmD, MBA

Consultant/paid advisory board: Daiichi Sankyo

Geno J. Merli, MD

Grants: Portola Pharmaceuticals, Inc

Tomás Villanueva, DO, MBA, FACPE, SFHM

Employment: Baptist Health Medical Group

Honoraria: American Regent; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Novo Nordisk

Donald C. Balfour III, MD, FACP; Jan Berger, MD, MJ; Joseph E. Biskupiak, PhD, MBA; Dennis B. Liotta, MD, MBA; Edmund J. Pezalla, MD, MPH; and Fadia T. Shaya, PhD, MPH, have no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: Standards of Care Issues With Anticoagulation in Real-World Populations